Roche Venture Fund, established in 2002, has invested in over 60 companies globally, with a current portfolio of around 30 companies across Europe, North America, and the Pacific Region. With CHF 500 million available, the fund is a long-term stable investor, co-investing with leading venture funds. It focuses on early-stage companies in the biotech and diagnostics industries, with investments ranging from $10 million to $50 million. The fund has no specific preference for the number of founders in portfolio startups, but startups need to be 6-10 years old to be eligible for investment. Roche Venture Fund has had a high level of activity, particularly in 2018, and has a lower exit rate compared to other organizations.